Medicines Co. (MDCO +10%) pushes through a 6-year high today as the stock surges after the drug...

|About: The Medicines Company (MDCO)|By:, SA News Editor

Medicines Co. (MDCO +10%) pushes through a 6-year high today as the stock surges after the drug maker announces positive Phase 3 trial results of its antiplatelet drug Cangrelor. Cangrelor demonstrated statistically significant improvement compared to clopidogrel, and MDCO intends to submit the results in the U.S. and E.U. for regulatory review in 2013.